Fundraising Fox

Koligo Therapeutics

Louisville, US · Founded 2016 · Kentucky corporation

Biotech

Founders & leadership

MB
Matthew B LehmanNamed on SEC filing
BA
Balamurugan AppakalaiNamed on SEC filing
SW
Stuart WilliamsNamed on SEC filing
MH
Michael HughesNamed on SEC filing
DB
David BlanfordNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$3.7M disclosed across 3 rounds · 2017–2020

▶$1.6MraisedOct 2020 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew LehmanExecutive Officer
Offering amount
$1.6M
Amount sold
$1.6M
Minimum investment
$20K
First sale
Sep 2020
Incorporated
Corporation, Kentucky
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedMar 2018 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael HughesExecutive Officer, Director
  • Stuart WilliamsExecutive Officer, Director
  • Matthew B LehmanExecutive Officer, Director
  • Balamurugan AppakalaiExecutive Officer, Director
  • David BlanfordExecutive Officer, Director
Offering amount
$2M
Amount sold
$2M
Proceeds to insiders
$100K
First sale
Mar 2018
Incorporated
Corporation, Kentucky, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5KraisedDec 2017 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew B LehmanExecutive Officer, Director
  • Balamurugan AppakalaiDirector
  • Stuart WilliamsDirector
  • Michael HughesDirector
  • David BlanfordDirector
Offering amount
$5K
Amount sold
$5K
Proceeds to insiders
$1K
First sale
Dec 2017
Incorporated
Corporation, Kentucky, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Koligo Therapeutics raised?
Koligo Therapeutics has disclosed $3.7M raised across 3 rounds.
Where is Koligo Therapeutics headquartered?
Koligo Therapeutics is headquartered in Louisville, US.